Education
About Us
Working with TipRanks
Follow Us
GoodRx Holdings (GDRX)
NASDAQ:GDRX
GDRX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.68 - $8.80
Previous CloseN/A
Volume261.88K
Average Volume (3M)1.19M
Market Cap
$1.57B
Enterprise Value$1.91B
Total Cash (Recent Filing)$300.98M
Total Debt (Recent Filing)$541.19M
Price to Earnings (P/E)58.4
Beta0.86
Next Earnings
Nov 06, 2025EPS Estimate
0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.09
Shares Outstanding100,300,160
10 Day Avg. Volume836,001
30 Day Avg. Volume1,194,960
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.22
Enterprise Value/Revenue2.40
Enterprise Value/Gross Profit2.62
Enterprise Value/Ebitda13.33
Forecast
1Y Price Target
$5.97Price Target Upside72.05% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
Bulls Say, Bears Say
Bulls Say
Leadership And StrategyThe appointment of Laura Jensen as Chief Commercial Officer and President of Pharma Solutions is seen positively.
Revenue GrowthPharma Manufacturer Solutions revenue was a bright spot in the quarter growing an impressive 32%.
Strategic ExpansionGoodRx's move into ED could lift subscription revenue by leveraging its broad consumer reach to challenge established players.
Bears Say
Financial PerformanceGoodRx reported weak 2Q results relative to consensus, with revenue, adj. EBITDA, and monthly active consumers below expectations.
Market ChallengesThe softness in Prescription Transaction revenue was driven by broader changes in the retail pharmacy landscape including pharmacy store closures.
Revenue GuidanceGoodRx lowered 2025 revenue guidance and adj. EBITDA guidance, with expectations of revenue headwind from the Rite Aid bankruptcy and volume reduction in one of the integrated savings programs.
GoodRx Holdings News
GDRX FAQ
What was GoodRx Holdings’s price range in the past 12 months?
GoodRx Holdings lowest stock price was $3.67 and its highest was $8.80 in the past 12 months.
What is GoodRx Holdings’s market cap?
GoodRx Holdings’s market cap is $1.57B.
When is GoodRx Holdings’s upcoming earnings report date?
GoodRx Holdings’s upcoming earnings report date is Nov 06, 2025 which is in 90 days.
How were GoodRx Holdings’s earnings last quarter?
GoodRx Holdings released its earnings results on Aug 06, 2025. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.099 by -$0.009.
Is GoodRx Holdings overvalued?
According to Wall Street analysts GoodRx Holdings’s price is currently Undervalued.
Does GoodRx Holdings pay dividends?
GoodRx Holdings does not currently pay dividends.
What is GoodRx Holdings’s EPS estimate?
GoodRx Holdings’s EPS estimate is 0.1.
How many shares outstanding does GoodRx Holdings have?
GoodRx Holdings has 100,300,160 shares outstanding.
What happened to GoodRx Holdings’s price movement after its last earnings report?
GoodRx Holdings reported an EPS of $0.09 in its last earnings report, missing expectations of $0.099. Following the earnings report the stock price went down -20.046%.
Which hedge fund is a major shareholder of GoodRx Holdings?
Currently, no hedge funds are holding shares in GDRX
GoodRx Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$5.97 (72.05% Upside)
$5.97 (72.05% Upside)
Blogger Sentiment
Bullish
GDRX Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 262.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $94.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 3.3%
Last 30 Days ▼ 3.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-50.34%
12-Months-Change
Fundamentals
Return on Equity
5.27%
Trailing 12-Months
Asset Growth
-10.91%
Trailing 12-Months
Company Description
GoodRx Holdings
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was incorporated in 2015 and is headquartered in Santa Monica, California.
GDRX Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presents a mixed outlook with several positive developments such as revenue growth, strong financial performance, and expanding manufacturer solutions. However, challenges like the Rite Aid bankruptcy, pressure on monthly active consumers, and macroeconomic uncertainties present potential setbacks.View all GDRX earnings summariesGDRX Revenue Breakdown
73.41% Prescription transactions
12.58% Subscription
11.34% Pharma manufacturer solutions
2.67% Other
GDRX Stock 12 Month Forecast
Average Price Target
$5.97
▲(72.05% Upside)
Technical Analysis
Ownership Overview
12.15% Insiders
13.90% Mutual Funds
0.44% Other Institutional Investors
62.60% Public Companies and Individual Investors